<code id='4162B12DE6'></code><style id='4162B12DE6'></style>
    • <acronym id='4162B12DE6'></acronym>
      <center id='4162B12DE6'><center id='4162B12DE6'><tfoot id='4162B12DE6'></tfoot></center><abbr id='4162B12DE6'><dir id='4162B12DE6'><tfoot id='4162B12DE6'></tfoot><noframes id='4162B12DE6'>

    • <optgroup id='4162B12DE6'><strike id='4162B12DE6'><sup id='4162B12DE6'></sup></strike><code id='4162B12DE6'></code></optgroup>
        1. <b id='4162B12DE6'><label id='4162B12DE6'><select id='4162B12DE6'><dt id='4162B12DE6'><span id='4162B12DE6'></span></dt></select></label></b><u id='4162B12DE6'></u>
          <i id='4162B12DE6'><strike id='4162B12DE6'><tt id='4162B12DE6'><pre id='4162B12DE6'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:56473
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk
          Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Melinda French Gates resigns from Gates Foundation

          MelindaFrenchGateswillstepdownasco-chairoftheBill&MelindaGatesFoundation.ChristopheEna/APMelinda